{"id":"W2947929331","doi":"10.1200/jco.2019.37.15_suppl.5576","title":"DPX-Survivac and intermittent low-dose cyclophosphamide (CPA) with or without epacadostat (E) in the treatment of subjects with advanced recurrent epithelial ovarian cancer (DeCidE<sup>1</sup> trial): T cell responses and tumor infiltration correlate with tumor regression.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Immunovaccine (Canada); Baker Hughes (Canada); Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Survivin; Immune system; T cell; Tumor microenvironment; Internal medicine; Oncology; Cyclophosphamide; Clinical trial; Chemotherapy; Ovarian cancer; Cancer; Urology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007614822,0.0005560422,0.001109395,0.0002769814,0.0001755344,0.000512674,0.000424496,0.0006708595,0.002192753],"category_scores_gemma":[0.0006265303,0.0002731591,0.000588662,0.0002993171,0.0005516447,0.0003181851,0.0001855022,0.001423655,0.0002474925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004082369,"about_ca_system_score_gemma":0.0008178448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008040085,"about_ca_topic_score_gemma":0.002557221,"domain_scores_codex":[0.9997522,0.0001377009,0.00001263009,0.00003608947,0.00002159266,0.00003982888],"domain_scores_gemma":[0.9995802,0.0001348406,0.00009768597,0.0000396978,0.00001811353,0.0001294683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8440235,0.01728171,0.008913031,0.0005878297,0.0008749065,0.00008685578,0.0001259391,0.0008710756,0.02179711,0.0002116769,0.001254731,0.1039715],"study_design_scores_gemma":[0.3973016,0.5572442,0.03353067,0.00005026519,0.0007741034,0.0002262304,0.00006334705,0.0009616349,0.007226435,0.0001341959,0.002453734,0.00003341238],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968151,0.001560037,0.0001089295,0.0001062919,0.00003716544,0.0003171245,0.0002417579,0.00002438234,0.0007891519],"genre_scores_gemma":[0.9959109,0.0009225565,0.0004723273,0.0001943747,0.00007481952,0.0003502581,0.0005707127,0.000006147198,0.001497908],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002192753,"threshold_uncertainty_score":0.007335544,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03445156899852991,"score_gpt":0.3608689255516176,"score_spread":0.3264173565530877,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}